Kailasam MT - Search Results

1

Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism.

Le Corre P, Parmer RJ, Kailasam MT, Kennedy BP, Skaar TP, Ho H, Leverge R, Smith DW, Ziegler MG, Insel PA, Schork NJ, Flockhart DA, O'connor DT. Le Corre P, et al. Among authors: kailasam mt. Clin Pharmacol Ther. 2004 Aug;76(2):139-53. doi: 10.1016/j.clpt.2004.04.010. Clin Pharmacol Ther. 2004. PMID: 15289791

2

Expression of altered alpha2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension.

Dao TT, Kailasam MT, Parmer RJ, Le HV, Le Verge R, Kennedy BP, Ziegler G, Insel PA, Wright FA, O'Connor DT. Dao TT, et al. Among authors: kailasam mt. J Hypertens. 1998 Jun;16(6):779-92. doi: 10.1097/00004872-199816060-00009. J Hypertens. 1998. PMID: 9663918

3

Variability in phenylephrine response and essential hypertension: a search for human alpha(1B)-adrenergic receptor polymorphisms.

Büscher R, Herrmann V, Ring KM, Kailasam MT, O'Connor DT, Parmer RJ, Insel PA. Büscher R, et al. Among authors: kailasam mt. J Pharmacol Exp Ther. 1999 Nov;291(2):793-8. J Pharmacol Exp Ther. 1999. PMID: 10525102

4

Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension.

O'Connor DT, Kailasam MT, Kennedy BP, Ziegler MG, Yanaihara N, Parmer RJ. O'Connor DT, et al. Among authors: kailasam mt. J Hypertens. 2002 Jul;20(7):1335-45. doi: 10.1097/00004872-200207000-00020. J Hypertens. 2002. PMID: 12131530 Clinical Trial.

5

Chromogranin A in human hypertension. Influence of heredity.

Takiyyuddin MA, Parmer RJ, Kailasam MT, Cervenka JH, Kennedy B, Ziegler MG, Lin MC, Li J, Grim CE, Wright FA, et al. Takiyyuddin MA, et al. Among authors: kailasam mt. Hypertension. 1995 Jul;26(1):213-20. doi: 10.1161/01.hyp.26.1.213. Hypertension. 1995. PMID: 7607727

6

Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension.

Kailasam MT, Parmer RJ, Cervenka JH, Wu RA, Ziegler MG, Kennedy BP, Adegbile IA, O'Connor DT. Kailasam MT, et al. Hypertension. 1995 Jul;26(1):143-9. doi: 10.1161/01.hyp.26.1.143. Hypertension. 1995. PMID: 7607717 Clinical Trial.

7

Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?

Wu RA, Kailasam MT, Cervenka JH, Parmer RJ, Kennedy BP, Ziegler MG, O'Connor DT. Wu RA, et al. Among authors: kailasam mt. J Hypertens. 1994 Nov;12(11):1243-7. J Hypertens. 1994. PMID: 7868871 Clinical Trial.

8

Effects of an oral prostaglandin E1 agonist on blood pressure and its determinants in essential hypertension.

Kailasam MT, Lin MC, Cervenka JH, Parmer RJ, Kennedy BP, Ziegler MG, O'Connor DT. Kailasam MT, et al. J Hum Hypertens. 1994 Jul;8(7):515-20. J Hum Hypertens. 1994. PMID: 7932515 Clinical Trial.

9

Complex trait genetics: new methods yield a result for essential hypertension.

O'Connor DT, Kailasam MT, Parmer RJ. O'Connor DT, et al. Among authors: kailasam mt. J Clin Invest. 1996 May 1;97(9):1997-8. doi: 10.1172/JCI118633. J Clin Invest. 1996. PMID: 8621786 Free PMC article. No abstract available.

10

Beta2-adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans.

Herrmann V, Büscher R, Go MM, Ring KM, Hofer JK, Kailasam MT, O'Connor DT, Parmer RJ, Insel PA. Herrmann V, et al. Among authors: kailasam mt. Am J Hypertens. 2000 Sep;13(9):1021-6. doi: 10.1016/s0895-7061(00)01188-2. Am J Hypertens. 2000. PMID: 10981553

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page